Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


NUSSBAUM SAMUEL R MD Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2021 4 NUSSBAUM SAMUEL R MD (Director) has filed a Form 4 on Motus GI Holdings, Inc.
Txns: Granted 30,000 shares @ $0
Granted 20,225 shares @ $0
Granted 30,000 options to buy @ $1.78, valued at $53.4k
01/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2020 4 NUSSBAUM SAMUEL R MD (Director) has filed a Form 4 on Motus GI Holdings, Inc.
Txns: Granted 7,200 shares @ $0
06/18/2020 3 NUSSBAUM SAMUEL R MD (Director) has filed a Form 3 on PROGENITY, INC.
02/07/2020 4 NUSSBAUM SAMUEL R MD (Director) has filed a Form 4 on Motus GI Holdings, Inc.
Txns: Granted 12,500 shares @ $0
Granted 12,500 options to buy @ $2.16, valued at $27k
01/14/2020 4 NUSSBAUM SAMUEL R MD (Director) has filed a Form 4 on Coherus BioSciences, Inc.
Txns: Granted 20,000 options to buy @ $17.73, valued at $354.6k
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2018 4 NUSSBAUM SAMUEL R MD (Director) has filed a Form 4 on Coherus BioSciences, Inc.
Txns: Granted 40,000 options to buy @ $15.6, valued at $624k
05/11/2018 3 NUSSBAUM SAMUEL R MD (Director) has filed a Form 3 on Coherus BioSciences, Inc.
02/21/2018 4 NUSSBAUM SAMUEL R MD (Director) has filed a Form 4 on Motus GI Holdings, Inc.
Txns: Bought 10,000 shares @ $5, valued at $50k
02/13/2018 3 NUSSBAUM SAMUEL R MD (Director) has filed a Form 3 on Motus GI Holdings, Inc.
05/21/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
05/13/2015 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on Anthem, Inc.
Txns: Sold 10,000 shares @ $160, valued at $1.6M
Exercised 10,000 options to buy @ $76.59, valued at $765.9k
04/15/2015 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on Anthem, Inc.
Txns: Sold 14,508 shares @ $154.29, valued at $2.2M
Sold 34,832 shares @ $155.06, valued at $5.4M
Exercised 46,667 options to buy @ $76.59, valued at $3.6M
Exercised 2,673 options to buy @ $30.1, valued at $80.5k
03/04/2015 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on Anthem, Inc.
Txns: Paid exercise price by delivering 4,809 shares @ $146.93, valued at $706.6k
Granted 2,553 shares @ $0
Granted 12,327 shares @ $0
Paid exercise price by delivering 2,856 shares @ $145.99, valued at $416.9k
Granted 11,177 options to buy @ $146.93, valued at $1.6M
11/04/2014 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Sold 40,000 shares @ $125, valued at $5M
Exercised 40,000 options to buy @ $63.36, valued at $2.5M
09/15/2014 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Sold 20,000 shares @ $120, valued at $2.4M
Exercised 20,000 options to buy @ $63.36, valued at $1.3M
09/09/2014 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Sold 18,244 shares @ $119, valued at $2.2M
Sold 20,000 shares @ $120, valued at $2.4M
Exercised 18,244 options to buy @ $70.8, valued at $1.3M
Exercised 20,000 options to buy @ $63.36, valued at $1.3M
08/29/2014 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Sold 35,000 shares @ $116.06, valued at $4.1M
Sold 5,000 shares @ $116, valued at $580k
Exercised 35,000 options to buy @ $70.8, valued at $2.5M
Exercised 5,000 options to buy @ $70.8, valued at $354k
03/05/2014 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Granted 15,756 shares @ $0
Granted 4,193 shares @ $0
Paid exercise price by delivering 7,654 shares @ $89.44, valued at $684.6k
Granted 17,113 options to buy @ $89.44, valued at $1.5M
09/17/2013 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Sold 117,512 shares @ $89.2, valued at $10.5M
Sold 117,512 shares @ $89.2, valued at $10.5M
Exercised 27,900 options to buy @ $44.18, valued at $1.2M
Exercised 27,900 options to buy @ $44.18, valued at $1.2M
Exercised 89,612 options to buy @ $30.1, valued at $2.7M
Exercised 89,612 options to buy @ $30.1, valued at $2.7M
09/13/2013 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Sold 42,100 shares @ $89.29, valued at $3.8M
Exercised 22,100 options to buy @ $44.18, valued at $976.4k
05/08/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/05/2013 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Granted 5,995 shares @ $0
Granted 7,273 shares @ $0
Paid exercise price by delivering 1,922 shares @ $61.88, valued at $118.9k
Granted 20,904 options to buy @ $61.88, valued at $1.3M
12/06/2012 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Granted 3,400 shares @ $0
03/05/2012 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Granted 16,142 shares @ $0
Granted 6,795 shares @ $0
Paid exercise price by delivering 4,254 shares @ $66.23, valued at $281.7k
Paid exercise price by delivering 5,690 shares @ $65.78, valued at $374.3k
Granted 18,506 options to buy @ $66.23, valued at $1.2M
02/04/2011 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT, INC
Txns: Granted 12,086 shares @ $0
03/03/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/05/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
03/04/2009 4 NUSSBAUM SAMUEL R MD (EVP & Chief Medical Officer) has filed a Form 4 on WELLPOINT INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy